Cambridge Investment Research Advisors’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$637K Sell
12,239
-315
-3% -$16.4K ﹤0.01% 2324
2025
Q1
$535K Sell
12,554
-4,043
-24% -$172K ﹤0.01% 2374
2024
Q4
$507K Buy
16,597
+6,769
+69% +$207K ﹤0.01% 2419
2024
Q3
$225K Buy
9,828
+41
+0.4% +$939 ﹤0.01% 3051
2024
Q2
$283K Sell
9,787
-16,692
-63% -$483K ﹤0.01% 2746
2024
Q1
$546K Buy
26,479
+1,641
+7% +$33.8K ﹤0.01% 2210
2023
Q4
$672K Sell
24,838
-846
-3% -$22.9K ﹤0.01% 1950
2023
Q3
$761K Buy
25,684
+11,498
+81% +$341K ﹤0.01% 1751
2023
Q2
$508K Sell
14,186
-393
-3% -$14.1K ﹤0.01% 2125
2023
Q1
$342K Buy
14,579
+6,464
+80% +$152K ﹤0.01% 2370
2022
Q4
$221K Buy
8,115
+2,074
+34% +$56.5K ﹤0.01% 2670
2022
Q3
$325K Buy
+6,041
New +$325K ﹤0.01% 2298
2022
Q1
Sell
-2,860
Closed -$286K 3218
2021
Q4
$286K Sell
2,860
-2,014
-41% -$201K ﹤0.01% 2566
2021
Q3
$609K Buy
4,874
+136
+3% +$17K ﹤0.01% 1897
2021
Q2
$588K Sell
4,738
-3,574
-43% -$444K ﹤0.01% 1927
2021
Q1
$1.27M Sell
8,312
-7,741
-48% -$1.18M 0.01% 1271
2020
Q4
$2.07M Buy
16,053
+7,639
+91% +$985K 0.01% 907
2020
Q3
$941K Buy
8,414
+2,720
+48% +$304K 0.01% 1224
2020
Q2
$462K Buy
5,694
+725
+15% +$58.8K ﹤0.01% 1600
2020
Q1
$346K Sell
4,969
-58
-1% -$4.04K ﹤0.01% 1592
2019
Q4
$393K Buy
5,027
+806
+19% +$63K ﹤0.01% 1738
2019
Q3
$269K Buy
+4,221
New +$269K ﹤0.01% 1907
2019
Q2
Sell
-3,070
Closed -$235K 2258
2019
Q1
$235K Buy
+3,070
New +$235K ﹤0.01% 1964